rs8179071
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002666.5(PLIN1):c.1043C>T(p.Ser348Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0108 in 1,614,084 control chromosomes in the GnomAD database, including 152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0070 ( 14 hom., cov: 33)
Exomes 𝑓: 0.011 ( 138 hom. )
Consequence
PLIN1
NM_002666.5 missense
NM_002666.5 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 3.13
Genes affected
PLIN1 (HGNC:9076): (perilipin 1) The protein encoded by this gene coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The encoded protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis. Alternatively spliced transcript variants varying in the 5' UTR, but encoding the same protein, have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.004059106).
BP6
Variant 15-89667102-G-A is Benign according to our data. Variant chr15-89667102-G-A is described in ClinVar as [Benign]. Clinvar id is 129969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-89667102-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00696 (1060/152286) while in subpopulation SAS AF= 0.0393 (190/4832). AF 95% confidence interval is 0.0347. There are 14 homozygotes in gnomad4. There are 529 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1060 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLIN1 | NM_002666.5 | c.1043C>T | p.Ser348Leu | missense_variant | 8/9 | ENST00000300055.10 | NP_002657.3 | |
PLIN1 | NM_001145311.2 | c.1043C>T | p.Ser348Leu | missense_variant | 8/9 | NP_001138783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLIN1 | ENST00000300055.10 | c.1043C>T | p.Ser348Leu | missense_variant | 8/9 | 1 | NM_002666.5 | ENSP00000300055 | P1 | |
PLIN1 | ENST00000430628.2 | c.1043C>T | p.Ser348Leu | missense_variant | 8/9 | 5 | ENSP00000402167 | P1 | ||
PLIN1 | ENST00000560330.1 | c.119C>T | p.Ser40Leu | missense_variant | 2/3 | 5 | ENSP00000453426 |
Frequencies
GnomAD3 genomes AF: 0.00698 AC: 1062AN: 152168Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1062
AN:
152168
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00979 AC: 2461AN: 251320Hom.: 35 AF XY: 0.0115 AC XY: 1563AN XY: 135872
GnomAD3 exomes
AF:
AC:
2461
AN:
251320
Hom.:
AF XY:
AC XY:
1563
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0112 AC: 16352AN: 1461798Hom.: 138 Cov.: 36 AF XY: 0.0118 AC XY: 8593AN XY: 727208
GnomAD4 exome
AF:
AC:
16352
AN:
1461798
Hom.:
Cov.:
36
AF XY:
AC XY:
8593
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00696 AC: 1060AN: 152286Hom.: 14 Cov.: 33 AF XY: 0.00710 AC XY: 529AN XY: 74462
GnomAD4 genome
AF:
AC:
1060
AN:
152286
Hom.:
Cov.:
33
AF XY:
AC XY:
529
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
36
ALSPAC
AF:
AC:
49
ESP6500AA
AF:
AC:
11
ESP6500EA
AF:
AC:
99
ExAC
AF:
AC:
1299
Asia WGS
AF:
AC:
49
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 31, 2014 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Aug 10, 2018 | ACMG criteria: BA1 (3.5% in gnomAD SA pop), BS2 (206 controls and 172 cases in T2DM) [REVEL 0.224, PP3 (5 predictors), BP4 (5 predictors)= conflicting evidence, not using]= benign - |
PLIN1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;D
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at